You just read:

Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus

News provided by

Medivir

Feb 22, 2011, 12:59 ET